[EN] PYRAZOLYL DERIVATIVES AS INHIBITORS OF THE KRAS MUTANT PROTEIN<br/>[FR] DÉRIVÉS DE PYRAZOLYLE EN TANT QU'INHIBITEURS DE LA PROTÉINE MUTANTE KRAS
申请人:NOVARTIS AG
公开号:WO2022269508A1
公开(公告)日:2022-12-29
The present invention provides a compound of formula (I), or a pharmaceutically acceptable salt thereof, and the therapeutic uses of said compound. The present invention further provides a pharmaceutical composition comprising said compound.
本发明提供了式(I)的化合物或其药学上可接受的盐,以及该化合物的治疗用途。本发明还提供了包含该化合物的药物组合物。